Walmart’s innovation is to clearly list and compete on prices, something currently missing from the healthcare industry in America.

Rather than restricting lifesaving innovations, the FDA should greenlight genetic testing and allow the market to develop.

According to its patients, this much talked about “right” to healthcare amounts to very little in reality.

Efforts to ban vaping are extremely unlikely to succeed and may push consumers toward harmful alternatives.

Increasing consumer exposure to prices and empowering them to pay medical expenses directly is key to keeping costs under control.

While the lobotomy offers a cautionary tale of medicine gone astray, it should also provide a cautionary tale of the harmful consequences of state-assisted health policies.

The vast majority of agency regulations were passed by “low-level officials and employees with no authority to issue rules.”

Gene therapies carry tremendous potential, but this upside can only be realized via the comprehensive and coordinated reform of federal policies.

To compete for FDA attention, drug makers now needed a way to navigate new safety hurdles to have their products approved.

Instead of reinventing the wheel, policymakers should work to reduce costs and bureaucracy within the current system.

Government efforts to regulate away vices can also motivate more dangerous or unhealthy behaviors.

After receiving access to experimental treatments, Natalie’s condition improved substantially.